Herpes Zoster Vaccines
Cross-source consensus on Herpes Zoster Vaccines from 1 sources and 3 claims.
1 sources · 3 claims
Uses
Benefits
Comparisons
Highlighted claims
- The two HZ vaccines, Zostavax and Shingrix, are effective in protecting individuals at highest risk of PHN. — Epidemiology and risk factors of postherpetic neuralgia worldwide: protocol for a systematic review and meta-analysis
- HZ vaccine access is predominantly limited to high-income countries because cost-effectiveness thresholds exclude them from national immunisation programmes in low- and middle-income countries. — Epidemiology and risk factors of postherpetic neuralgia worldwide: protocol for a systematic review and meta-analysis
- The systematic review will examine vaccine-targetable risk factors as a secondary objective. — Epidemiology and risk factors of postherpetic neuralgia worldwide: protocol for a systematic review and meta-analysis